Public Health

Big Pharma’s anti-competitive practice costs consumers $3.5 billion a year. The 1984 Hatch-Waxman Act was originally intended to increase the availability of generic drugs by allowing generic manufacturers to challenge the patents of name-brand drugs. What emerged in the aftermath was a practice where patent-holding pharmaceutical companies simply paid generic manufacturers not to challenge their patents, thus delaying the release of generic drugs for years. 

Issue | Health Care

Making Health Care Work

Fighting to control the skyrocketing cost of health care.

Result | Public Health

KIDS’ SCHOOL LUNCHES NOW SAFER

For years, America’s schoolchildren have been eating beef, chicken and other foods that would have been rejected as substandard even by fast food chains. Thanks in part to our advocacy, the U.S.D.A. has stopped buying such low-quality meat for school lunches.

Pages

Subscribe to RSS - Public Health

BAN ROUNDUP

We're calling on the EPA to ban Monsanto's Roundup unless and until independent research proves it's safe. Let's hold them accountable.

Support Us

Your donation supports CALPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code